VP, Experimental Pharmacology @ (December 2005 - December 2011)
Vice President, Clinical Operations and Clinical Pharmacology @ (December 2003 - November 2005)
General Manager, Corporate Strategy @ (December 2002 - December 2003)
Sr. VP, Development @ (June 1996 - December 2002)
VP, Development @ (September 1991 - May 1996)
Dir., Preclinical Pharmaceutical Development @ Cholestech, Inc. (August 1990 - July 1991)
Group Leader and Project Manager @ Penederm, Inc. (August 1989 - July 1990)
Scientist and Project Team Leader @ Genentech, Inc. (February 1985 - August 1989)
Senior Scientist and Head, Clinical Support and PK @ Lederle Laboratories Division of American Cyanamid Co. (October 1982 - February 1985)
Robert Baughman Education
University of California, San Francisco 1974-1982
Loyola Marymount University 1969-1974
Robert Baughman Skills
Clinical Trials
Pharmacokinetics
Pharmacodynamics
Clinical Development
Drug Development
IND
Biotechnology
Drug Discovery
Regulatory Submissions
Good Laboratory Practice Glp
CRO
Clinical Pharmacology
Clinical Research
CTMS
Good Clinical Practice Gcp
Regulatory Affairs
Drug Delivery
CRO Management
GCP
Pharmaceutics
u.s. Food and Drug Administration Fda
Clinical Operations
Pharmacology
Diabetes
Pharmaceutical Industry
GLP
FDA
Sop
u.s. Food and Drug Administration
Good Clinical Practice
Good Laboratory Practice
Robert Baughman Summary
Robert Baughman, based in Ridgefield, CT, US, is currently a Dir., Clinical Pharmacology and DMPK at Amgen (formerly Horizon). Robert Baughman brings experience from previous roles at Marinus Pharmaceuticals, Takeda Pharmaceuticals (formerly Shire), Applied Molecular Transport and MannKind Corporation. Robert Baughman holds a 1974 - 1982 University of California, San Francisco. With a robust skill set that includes Clinical Trials, Pharmacokinetics, Pharmacodynamics, Clinical Development, Drug Development and more. Robert Baughman has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Robert Baughman?
Find contact details for 700 million professionals.